Browsing byAuthorHardcastle, N

Jump to a point in the index:
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
2021-08-29Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)Siva, S; Bressel, M; Mai, T; Le, H; Vinod, S; de Silva, H; Macdonald, S; Skala, M; Hardcastle, N; Rezo, A; Pryor, D; Gill, S; Higgs, B; Wagenfuehr, K; Montgomery, R; Awad, R; Chesson, B; Eade, T; Wong, W; Sasso, G; De Abreu Lourenco, R; Kron, T; Ball, D; Neeson, P; Bettington, C; Cook, O; Foote, M; Gowda, R; Haas, M; Haynes, NM; Hilder, B; Lao, L; Lim, A; Ludbrook, J; Jansen, T; MacManus, M; McCullough, SA; Moore, A; Ritchie, D; Shaw, M; Sia, J; Syed, F; Tang, C; Trapani, J
2021-05-03Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoringLee, YYD; Nguyen, DT; Moodie, T; O’Brien, R; McMaster, A; Hickey, A; Pritchard, N; Poulsen, P; Tabaksblat, EM; Weber, B; Worm, E; Pryor, D; Chu, J; Hardcastle, N; Booth, J; Gebski, V; Wang, T; Keall, P
2020-11-03MLC tracking for lung SABR is feasible, efficient and delivers high-precision target dose and lower normal tissue dose.Booth, J; Caillet, V; Briggs, A; Hardcastle, N; Angelis, G; Jayamanne, D; Shepherd, M; Podreka, A; Szymura, K; Nguyen, DT; Poulsen, P; O'Brien, R; Harris, B; Haddad, C; Eade, T; Keall, P
2020-10Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial.Hewson, EA; Nguyen, DT; O'Brien, R; Poulsen, PR; Booth, JT; Greer, P; Eade, T; Kneebone, A; Hruby, G; Moodie, T; Hayden, AJ; Turner, SL; Hardcastle, N; Siva, S; Tai, KH; Martin, J; Keall, PJ
2020-07Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial.Keall, P; Nguyen, DT; O'Brien, R; Hewson, E; Ball, H; Poulsen, P; Booth, J; Greer, P; Hunter, P; Wilton, L; Bromley, R; Kipritidis, J; Eade, T; Kneebone, A; Hruby, G; Moodie, T; Hayden, A; Turner, S; Arumugam, S; Sidhom, M; Hardcastle, N; Siva, S; Tai, K-H; Gebski, V; Martin, J
2019-11-01The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trialHewson, EA; Nguyen, DT; O’Brien, R; Kim, JH; Montanaro, T; Moodie, T; Greer, PB; Hardcastle, N; Eade, T; Kneebone, A; Hruby, G; Hayden, AJ; Turner, S; Siva, S; Tai, KH; Hunter, P; Sams, J; Poulsen, PR; Booth, JT; Martin, J; Keall, PJ
2018-10-23TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1112 Oncology and CarcinogenesisSiva, S; Chesson, B; Bressel, M; Pryor, D; Higgs, B; Reynolds, HM; Hardcastle, N; Montgomery, R; Vanneste, B; Khoo, V; Ruben, J; Lau, E; Hofman, MS; De Abreu Lourenco, R; Sridharan, S; Brook, NR; Martin, J; Lawrentschuk, N; Kron, T; Foroudi, F
2018-10-09An augmented correlation framework for the estimation of tumour translational and rotational motion during external beam radiotherapy treatments using intermittent monoscopic x-ray imaging and an external respiratory signalNguyen, DT; Booth, JT; Caillet, V; Hardcastle, N; Briggs, A; Haddad, C; Eade, T; O'Brien, R; Keall, PJ
2016-03-04A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)Siva, S; Kron, T; Bressel, M; Haas, M; Mai, T; Vinod, S; Sasso, G; Wong, W; Le, H; Eade, T; Hardcastle, N; Chesson, B; Pham, D; Høyer, M; Montgomery, R; Ball, D